Earlier in April, doctors at the National Institutes of Health made a promising step in the fight against cancer, announcing an immunotherapy treatment was able to shrink gastrointestinal tumors for about a quarter of patients. But NIH staffing shortages, layoffs and cuts are threatening to delay the rollout of this promising development. William Brangham speaks with Dr. Steven Rosenberg for more.
Categories